Applied Finance Capital Management, LLC
Source: SEC Form 13F · as of Mar 2026Applied Finance Capital Management, LLC holds 19 biotech & pharma companies tracked by BioSniper, totaling $92.8M in value as of Mar 2026 (SEC Form 13F).
Companies held
19
Total value held
$92.8M
| Company | Shares | Value |
|---|---|---|
| MRKMerck & Co., Inc. | 178,906 | $21.5M |
| MCKMcKesson Corporation | 17,759 | $15.4M |
| REGNREGENERON PHARMACEUTICALS, INC. | 16,835 | $13.0M |
| INCYIncyte Corp. | 126,406 | $11.9M |
| JNJJOHNSON & JOHNSON | 37,175 | $9.1M |
| ABBVAbbVie Inc. | 30,071 | $6.5M |
| AMGNAMGEN INC | 9,033 | $3.2M |
| GILDGILEAD SCIENCES, INC. | 20,287 | $2.8M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 9,038 | $2.4M |
| PFEPFIZER INC | 46,635 | $1.3M |
| NVSNovartis AG | 7,171 | $1.1M |
| ZTSZoetis Inc. | 8,363 | $989K |
| LLYELI LILLY & Co | 944 | $868K |
| ABTABBOTT LABORATORIES | 7,117 | $731K |
| IQVIQVIA Holdings Inc. | 3,635 | $620K |
| GEHCGE HealthCare Technologies Inc. | 5,170 | $368K |
| BIIBBIOGEN INC. | 1,842 | $338K |
| UTHRUNITED THERAPEUTICS Corp | 566 | $336K |
| DVADaVita Inc. | 1,717 | $264K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.